Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility

References

• Hyett B, Martinez FJ, Gill BM, Mehra S, Lembo A, Kelly CP, Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology 2009;137:445–52.
   PubMedGoogle Scholar
• Jung HK, Choung RS, Locke GR, Schleck CD, Zinsmeister AR, Szarka LA, The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996–2006. Gastroenterology 2009;136:1225–33.
   PubMed Web of Science ®Google Scholar
• Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984;14:420–7.
   PubMed Web of Science ®Google Scholar
• Bonapace ES, Maurer AH, Davidoff S, Krevsky B, Fisher RS, Parkman HP. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol 2000;95:2838–47.
   PubMedGoogle Scholar
• Kuemmerle JF. Motility disorders of the small intestine: new insights into old problems. J Clin Gastroenterol 2000;31:276–81.
   PubMedGoogle Scholar
• Haruma K, Wiste JA, Camilleri M. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders. Gut 1994;35:1064–9.
   PubMedGoogle Scholar
• Peeters TL, Janssens J, Vantrappen GR. Somatostatin and the interdigestive migrating motor complex in man. Regul Pept 1983;5:209–17.
   PubMedGoogle Scholar
• Foxx-Orenstein A, Camilleri M, Stephens D, Burton D. Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans. Gut 2003;52:1555–61.
   PubMed Web of Science ®Google Scholar
• Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol 1990;259:G355–63.
   Google Scholar
• Tomomasa T, Karoumi T, Arai H, Wakabayashi K, Itoh Z. Erythromycin induces migrating motor complex in human gastrointestinal tract. Dig Dis Sci 1986;31:157–61.
   PubMed Web of Science ®Google Scholar
• Itoh Z, Nakaya M, Suzuki T, Arai H, Wakabayashi K. Erythromycin mimics exogenous motilin in gastrointestinal tract activity in the dog. Am J Physiol 1984;247:G688–G94.
   Google Scholar
• Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil 1999;11:141–61.
   PubMed Web of Science ®Google Scholar
• Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM. Oral erythromycin and the risk of sudden death from cardiac issues. N Engl J Med 2004;351:1089–96.
   PubMed Web of Science ®Google Scholar
• Hopkins S. Clinical toleration and safety of azithromycin. Am J Med 1991;91:40S–5S.
   PubMed Web of Science ®Google Scholar
• Sifrim D, Matsuo H, Janssens J, Vantrappen G. Comparison of the effects of midecamycin acetate and azithromycin on gastrointestinal motility in man. Drugs Exp Clin Res 1994;20:121–6.
   PubMedGoogle Scholar
• Sutera L, Dominguez LJ, Belvedere M, Putignano E, Vernuccio L, Ferlisi A, Azithromycin in an older woman with diabetic gastroparesis. Am J Ther 2008;15:85–8.
   PubMed Web of Science ®Google Scholar
• Moshiree B, McDonald R, Hou W, Toskes PP. Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis. Dig Dis Sci 2009;55:675–83.
   Google Scholar
• Thumshirn M, Bruninga K, Camilleri M. Simplifying the evaluation of postprandial antral motor function in patients with suspected gastroparesis. Am J Gastroenterol 1997;92:1496–500.
   PubMedGoogle Scholar
• Bortolotti M, Annese V, Coccia G. Twenty-four hour ambulatory antroduodenal manometry in normal subjects (co-operative study). Neurogastroenterol Motil 2000;12:231–8.
   PubMed Web of Science ®Google Scholar
• Parkman HP, Trate DM, Knight LC, Brown KL, Maurer AH, Fisher RS. Cholinergic effects on human gastric motility. Gut 1999;45:346–54.
   PubMed Web of Science ®Google Scholar
• Amsden GW. Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 1996;18:56–72.
   PubMed Web of Science ®Google Scholar
• Desautels SG, Hutson WR, Christian PE, Moore JG, Datz FL. Gastric emptying response to variable oral erythromycin dosing in diabetic gastroparesis. Dig Dis Sci 1995;40:141–6.
   PubMedGoogle Scholar
• Rubinstein E. Comparative safety of the different macrolides. Int J Antimicrob Agents 2001;18:S71–6.
   PubMed Web of Science ®Google Scholar
• Rapp RP. Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions. Ann Pharmacother 1998;32:785–93.
   PubMed Web of Science ®Google Scholar
• Tougas G, Chen Y, Coates G, Paterson W, Dallaire C, Pare P, Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol 2000;95:78–86.
   PubMedGoogle Scholar